Impact of a Virtual Reality-based Mindfulness Program on Clinician Wellness

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorUniversity of Massachusetts, Worcester

About this trial

Burnout shares symptoms with anxiety and depression. While there is no single intervention for burnout, there are validated interventions (which are amenable to virtual reality (VR)) for anxiety and depression. UMassMemorial data from the Professional Well-Being Academic Consortium show that MD burnout and distress has increased since 2020. The investigators believe providing clinicians with a unique tool (VR) will be a feasible and efficacious way to tackle distress. It is known that only 1% of our MDs have done mindfulness training but nearly 50% are interested in doing so. Therefore, a self-administrable, interactive mindfulness program delivered over VR has great potential to reach clinicians who want to practice a more active form of mindfulness at a time convenient to them. The results of the study will provide preliminary evidence to determine if a take-home VR mindfulness program decreases clinician stress.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

physician or APP employed by the Medical Group

Disqualifiers

Not willing to receive 2 texts per week

Trial design

Design model

Parallel

Treatments tested in this trial

  • VR mindfulness

    Behavioral

    VR-based mindfulness

Treatment groups

32 Participants
are divided into 2 treatment groups
Group A: Intervention - VR MindfulnessExperimental treatment 1 intervention
Group B: ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

PROMIS - anxiety

PROMIS Short Form - anxiety scale. Scores of 8-40; Higher is a worse outcome.

Time frame
at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the intervention group at 12 and 24 weeks to their baseline.
2

PROMIS - anxiety

PROMIS Short Form - anxiety scale. Scores of 8-40; Higher is a worse outcome.

Time frame
at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the control group at 12 and 24 weeks to their baseline.
3

PROMIS - Depression

PROMIS Short Form - Depression scale. Scores of 8-40; Higher is a worse outcome.

Time frame
at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the intervention group at 12 and 24 weeks to their baseline.
4

PROMIS - Depression

PROMIS Short Form - Depression scale. Scores of 8-40; Higher is a worse outcome.

Time frame
at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the control group at 12 and 24 weeks to their baseline.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: